Charles Schwab’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $21.6M | Sell |
|
|||||
|
2025
Q2 | $16.8M | Buy |
|
|||||
|
2025
Q1 | $16M | Buy |
|
|||||
|
2024
Q4 | $13.1M | Sell |
|
|||||
|
2024
Q3 | $14.9M | Buy |
|
|||||
|
2024
Q2 | $15.4M | Buy |
|
|||||
|
2024
Q1 | $13.6M | Buy |
|
|||||
|
2023
Q4 | $8.11M | Buy |
|
|||||
|
2023
Q3 | $8.53M | Buy |
|
|||||
|
2023
Q2 | $2.04M | Buy |
|
|||||
|
2023
Q1 | $1.39M | Buy |
|
|||||
|
2022
Q4 | $1.39M | Buy |
|
|||||
|
2022
Q3 | $1.07M | Buy |
|
|||||
|
2022
Q2 | $970K | Buy |
|
|||||
|
2022
Q1 | $821K | Buy |
|
|||||
|
2021
Q4 | $1.32M | Buy |
|
|||||
|
2021
Q3 | $802K | Sell |
|
|||||
|
2021
Q2 | $2.43M | Buy |
|
|||||
|
2021
Q1 | $2.15M | Sell |
|
|||||
|
2020
Q4 | $1.86M | Buy |
|
|||||
|
2020
Q3 | $1.78M | Buy |
|
|||||
|
2020
Q2 | $2.03M | Buy |
|
|||||
|
2020
Q1 | $2.38M | Sell |
|
|||||
|
2019
Q4 | $6.09M | Buy |
|
|||||
|
2019
Q3 | $7.12M | Sell |
|
|||||
|
2019
Q2 | $8.35M | Sell |
|
|||||
|
2019
Q1 | $8.67M | Buy |
|
|||||
|
2018
Q4 | $5.42M | Buy |
|
|||||
|
2018
Q3 | $5.98M | Buy |
|
|||||
|
2018
Q2 | $5.58M | Buy |
|
|||||
|
2018
Q1 | $3.6M | Sell |
|
|||||
|
2017
Q4 | $4.17M | Buy |
|
|||||
|
2017
Q3 | $2.45M | Buy |
|
|||||
|
2017
Q2 | $1.99M | Buy |
|
|||||
|
2017
Q1 | $1.93M | Buy |
|
|||||
|
2016
Q4 | $1.72M | Buy |
|
|||||
|
2016
Q3 | $1.78M | Buy |
|
|||||
|
2016
Q2 | $754K | Hold |
|
|||||
|
2016
Q1 | $455K | Sell |
|
|||||
|
2015
Q4 | $1.07M | Buy |
|
|||||
|
2015
Q3 | $802K | Buy |
|
|||||
|
2015
Q2 | $1.1M | Buy |
|
|||||
|
2015
Q1 | $632K | Hold |
|
|||||
|
2014
Q4 | $570K | Hold |
|
|||||
|
2014
Q3 | $286K | Hold |
|
|||||
|
2014
Q2 | $348K | Buy |
|